| pubmed-article:16377680 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C0004613 | lld:lifeskim |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C1512910 | lld:lifeskim |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C0536495 | lld:lifeskim |
| pubmed-article:16377680 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:16377680 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16377680 | pubmed:dateCreated | 2005-12-26 | lld:pubmed |
| pubmed-article:16377680 | pubmed:abstractText | The in vitro activity of moxifloxacin against 923 recent anaerobic isolates obtained from pretreatment cultures in patients with complicated intra-abdominal infections was studied using the CLSI M11-A-6 agar dilution method. Moxifloxacin was active against 87% (96 of 110) Bacteroides fragilis strains at < or = 1 microg/ml and 87% (79 of 90) B. thetaiotaomicron strains at < or = 2 microg/ml. Species variation was seen, with B. uniformis, B. vulgatus, Clostridium clostridioforme, and C. symbiosum being least susceptible and accounting for most of the resistant isolates; excluding the aforementioned four resistant species, 86% (303 of 363) of Bacteroides species isolates and 94% (417 of 450) of all other genera and species were susceptible to < or = 2 microg/ml of moxifloxacin. Overall, moxifloxacin was active against 763 of 923 (83%) of strains at < or = 2 microg/ml, supporting its use as a monotherapy for some community-acquired intra-abdominal infections. | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16377680 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16377680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16377680 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16377680 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:16377680 | pubmed:issn | 0066-4804 | lld:pubmed |
| pubmed-article:16377680 | pubmed:author | pubmed-author:GoldsteinElli... | lld:pubmed |
| pubmed-article:16377680 | pubmed:author | pubmed-author:CitronDiane... | lld:pubmed |
| pubmed-article:16377680 | pubmed:author | pubmed-author:MerriamC... | lld:pubmed |
| pubmed-article:16377680 | pubmed:author | pubmed-author:WarrenYumi... | lld:pubmed |
| pubmed-article:16377680 | pubmed:author | pubmed-author:TyrrellKerin... | lld:pubmed |
| pubmed-article:16377680 | pubmed:author | pubmed-author:FernandezHele... | lld:pubmed |
| pubmed-article:16377680 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16377680 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:16377680 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16377680 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16377680 | pubmed:pagination | 148-55 | lld:pubmed |
| pubmed-article:16377680 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:meshHeading | pubmed-meshheading:16377680... | lld:pubmed |
| pubmed-article:16377680 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16377680 | pubmed:articleTitle | In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections. | lld:pubmed |
| pubmed-article:16377680 | pubmed:affiliation | R. M. Alden Research Laboratory, 2021 Santa Monica Blvd., Suite #740 East, Santa Monica, California 90404, USA. ejcgmd@aol.com | lld:pubmed |
| pubmed-article:16377680 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16377680 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16377680 | lld:pubmed |
